Tony Tramontin is the Chief Scientific Officer at Axcella Health, a Boston biotechnology company focused on metabolic modulation. Tony leads Research and Development activities including Discovery, Preclinical Development, Technical Development, Formulation, Manufacturing, and Strategic Innovation.
Prior to Axcella, Tony was a Partner in McKinsey & Company’s Global Healthcare Practice. Across a 15 year career, he advised biopharma executives on a wide variety of strategic, operational and organizational topics across the value chain. The majority of his work, however, focused specifically on research, drug development and early aspects of commercialization. He co-founded and led McKinsey’s technical service line that helped biopharma executives with R&D project investment decisions, portfolio prioritization, risk management, therapeutic area strategy, and product launch strategy.
Before joining McKinsey, Tony was an experimental neuroscientist conducting stem cell research at The Rockefeller University and at The University of California San Francisco Department of Neurosurgery.